Skip to main content
Smart Investors Daily
Teleflex Incorporated logo

NYSE · TFX

Teleflex Incorporated

Healthcare · Medical - Instruments & Supplies

$165.85

Down-$2.45 (-1.48%)

Updated Nov 20, 2026, 1:12 AM

SID Score

6.7/10

Composite research score

Smart Money

58/100

Neutral

Market cap
5.63B
P/E ratio
-17.18
Dividend yield
0.82%
52-week range
$100.18 – $166.75
Volume
1.16M
Avg. volume
634.31K

Price performance · TFX

TFX price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 18, 2026

TFX closed at $165.85 after 20 trading sessions, up 21.43% for the selected period.

Last close
$165.85
Period change
+21.43%
Period low
$136.29
Period high
$165.85
Daily close
View OHLC price history
TFX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 18, 2026$157.84$166.75$157.495$165.851.16M
Nov 17, 2026$155.70$161.00$155.70$159.551.59M
Nov 16, 2026$155.00$157.65$154.63$157.10799.56K
Nov 13, 2026$153.58$156.30$153.58$155.10836.4K
Nov 12, 2026$156.71$156.75$153.10$153.15604.04K
Nov 11, 2026$155.93$156.47$153.88$156.33610.44K
Nov 10, 2026$154.00$156.4294$152.56$155.30748.06K
Nov 9, 2026$151.56$156.208$148.25$154.73994.01K
Nov 6, 2026$148.43$153.04$146.74$150.87948.15K
Nov 5, 2026$149.43$156.67$149.135$152.151.42M
Nov 4, 2026$141.39$150.04$141.39$149.871.29M
Nov 3, 2026$141.00$141.8499$137.00$139.951.27M
Nov 2, 2026$140.25$141.585$138.328$140.67923.1K
Oct 30, 2026$142.06$142.86$138.96$139.77891.28K
Oct 29, 2026$140.10$142.045$138.92$141.39837.98K
Oct 28, 2026$138.03$140.30$136.92$138.98630.14K
Oct 27, 2026$136.33$139.12$135.32$139.00878.87K
Oct 26, 2026$134.36$138.064$130.48$136.80683.01K
Oct 23, 2026$136.45$137.55$135.00$136.29505.1K
Oct 22, 2026$132.30$137.015$131.265$136.58697.97K

Latest TFX news

The latest Smart Investors Daily articles mentioning TFX.

TFX research

Overview

Company profile and research snapshot.

Company profile

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$129.50
Implied upside
—
Analysts
—
TFX recent ratings
DateFirmRatingTarget
Nov 9, 2026Truist SecuritiesHold—
Nov 6, 2026RBC CapitalOutperform—
Nov 6, 2026Wells FargoEqual-Weight—
Oct 14, 2026Truist SecuritiesHold—
Sep 28, 2026B of A SecuritiesBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 11, 2026

Learn Why The Bull Case For Teleflex Stock Could Change Following Raised EPS Guidance

Teleflex reported third quarter 2026 sales of US$567.78 million and net income of US$927.43 million, raised full year GAAP EPS guidance, continued a sizeable buyback program, and affirmed a US$0.34 quarterly dividend payable on December 31, 2026. Management plans to keep directing excess cash toward share repurchases and potential tuck in acquisitions that align with its three core businesses, pairing this with R&D and CapEx investment to support the current transformation program. The next...

Yahoo · Nov 10, 2026

Teleflex (TFX) Stock Gets Fair Value Bump After Split Analyst Views

Teleflex’s updated valuation framework now points to a fair value of about US$161.82, up from roughly US$154.73, which may catch the eye of investors tracking model based price targets. This shift lines up with a research backdrop where some analysts highlight execution and integration progress, while others stay cautious around procedure trends and hospital spending, leading to a wide spread of Street targets. In the sections that follow, you will see what is driving this evolving Teleflex...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.